10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2018 | |||
Consolidated Statements of Earnings | |||
Period Ending Dec 30, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 30, 2018 | Dec 31, 2017 | Jan 1, 2017 | |
| Sales to customers | $ 81,581 | 76,450 | 71,890 |
| Cost of products sold | 27,091 | 25,439 | 21,789 |
| Gross profit | 54,490 | 51,011 | 50,101 |
| Selling, marketing and administrative expenses | 22,540 | 21,520 | 20,067 |
| Research and development expense | 10,775 | 10,594 | 9,143 |
| In-process research and development | 1,126 | 408 | 29 |
| Interest income | (611) | (385) | (368) |
| Interest expense, net of portion capitalized (Note 4) | 1,005 | 934 | 726 |
| Other (income) expense, net | 1,405 | (42) | 210 |
| Restructuring (Note 22) | 251 | 309 | 491 |
| Earnings before provision for taxes on income | 17,999 | 17,673 | 19,803 |
| Provision for taxes on income (Note 8) | 2,702 | 16,373 | 3,263 |
| Net earnings | 15,297 | 1,300 | 16,540 |
| Net earnings per share (Notes 1 and 15) | |||
| Basic (in dollars per share) | 5.70 | 0.48 | 6.04 |
| Diluted (in dollars per share) | 5.61 | 0.47 | 5.93 |
| Average shares outstanding (Notes 1 and 15) | |||
| Basic (in shares) | 2,681,500 | 2,692,000 | 2,737,300 |
| Diluted (in shares) | 2,728,700 | 2,745,300 | 2,788,900 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2018 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 30, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 30, 2018 | Dec 31, 2017 | Jan 1, 2017 | |
| Net earnings | $ 15,297 | 1,300 | 16,540 |
| Other Comprehensive Income (Loss), net of tax | |||
| Foreign currency translation | (1,518) | 1,696 | (612) |
| Securities | |||
| Unrealized holding gain (loss) arising during period | (1) | 159 | (52) |
| Reclassifications to earnings | 1 | (338) | (141) |
| Net change | 0 | (179) | (193) |
| Employee benefit plans | |||
| Prior service credit (cost), net of amortization | (44) | 2 | 21 |
| Gain (loss), net of amortization | (56) | 29 | (862) |
| Effect of exchange rates | 92 | (201) | 159 |
| Net change | (8) | (170) | (682) |
| Derivatives & hedges | |||
| Unrealized gain (loss) arising during period | (73) | (4) | (359) |
| Reclassifications to earnings | (192) | 359 | 110 |
| Net change | (265) | 355 | (249) |
| Other comprehensive income (loss) | (1,791) | 1,702 | (1,736) |
| Comprehensive income | 13,506 | 3,002 | 14,804 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 30, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 30, 2018 | Dec 31, 2017 | Jan 1, 2017 | |
| Cash flows from operating activities | |||
| Net earnings | $ 15,297 | 1,300 | 16,540 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 6,929 | 5,642 | 3,754 |
| Stock based compensation | 978 | 962 | 878 |
| Asset write-downs | 1,258 | 795 | 283 |
| Gain on sale of assets/businesses | (1,217) | (1,307) | (563) |
| Deferred tax provision | (1,016) | 2,406 | (341) |
| Accounts receivable allowances | (31) | 17 | (11) |
| Changes in assets and liabilities, net of effects from acquisitions and divestitures: | |||
| Increase in accounts receivable | (1,185) | (633) | (1,065) |
| (Increase)/Decrease in inventories | (644) | 581 | (249) |
| Increase in accounts payable and accrued liabilities | 3,951 | 2,725 | 656 |
| Increase in other current and non-current assets | (275) | (411) | (529) |
| (Decrease)/Increase in other current and non-current liabilities | (1,844) | 8,979 | (586) |
| Net cash flows from operating activities | 22,201 | 21,056 | 18,767 |
| Cash flows from investing activities | |||
| Additions to property, plant and equipment | (3,670) | (3,279) | (3,226) |
| Proceeds from the disposal of assets/businesses, net | 3,203 | 1,832 | 1,267 |
| Acquisitions, net of cash acquired (Note 20) | (899) | (35,151) | (4,509) |
| Purchases of investments | (5,626) | (6,153) | (33,950) |
| Sales of investments | 4,289 | 28,117 | 35,780 |
| Other (primarily intangibles) | (464) | (234) | (123) |
| Net cash used by investing activities | (3,167) | (14,868) | (4,761) |
| Cash flows from financing activities | |||
| Dividends to shareholders | (9,494) | (8,943) | (8,621) |
| Repurchase of common stock | (5,868) | (6,358) | (8,979) |
| Proceeds from short-term debt | 80 | 869 | 111 |
| Retirement of short-term debt | (2,479) | (1,330) | (2,017) |
| Proceeds from long-term debt, net of issuance costs | 5 | 8,992 | 12,004 |
| Retirement of long-term debt | (1,555) | (1,777) | (2,223) |
| Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | 949 | 1,062 | 1,189 |
| Other | (148) | (188) | (15) |
| Net cash used by financing activities | (18,510) | (7,673) | (8,551) |
| Effect of exchange rate changes on cash and cash equivalents | (241) | 337 | (215) |
| Increase/(Decrease) in cash and cash equivalents | 283 | (1,148) | 5,240 |
| Cash and cash equivalents, beginning of year (Note 1) | 17,824 | 18,972 | |
| Cash and cash equivalents, end of year (Note 1) | 18,107 | 17,824 | 18,972 |
| Supplemental cash flow data | |||
| Cash paid during the year for: | |||
| Interest | 1,049 | 960 | 730 |
| Interest, net of amount capitalized | 963 | 866 | 628 |
| Income taxes | 4,570 | 3,312 | 2,843 |
| Supplemental schedule of non-cash investing and financing activities | |||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards | 2,095 | 2,062 | 2,043 |
| Conversion of debt | 6 | 16 | 35 |
| Acquisitions | |||
| Fair value of assets acquired | 1,047 | 36,937 | 4,586 |
| Fair value of liabilities assumed and noncontrolling interests | (148) | (1,786) | (77) |
| Net cash paid for acquisitions | 899 | 35,151 | 4,509 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 30, 2018 10-K (Filed: Feb 20, 2019) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 30, 2018 | Dec 31, 2017 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 18,107 | 17,824 |
| Marketable securities (Notes 1 and 2) | 1,580 | 472 |
| Accounts receivable trade, less allowances for doubtful accounts $248 (2017, $291) | 14,098 | 13,490 |
| Inventories (Notes 1 and 3) | 8,599 | 8,765 |
| Prepaid expenses and other receivables | 2,699 | 2,537 |
| Assets held for sale (Note 20) | 950 | 0 |
| Total current assets | 46,033 | 43,088 |
| Property, plant and equipment, net (Notes 1 and 4) | 17,035 | 17,005 |
| Intangible assets, net (Notes 1 and 5) | 47,611 | 53,228 |
| Goodwill (Notes 1 and 5) | 30,453 | 31,906 |
| Deferred taxes on income (Note 8) | 7,640 | 7,105 |
| Other assets | 4,182 | 4,971 |
| Total assets | 152,954 | 157,303 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Loans and notes payable (Note 7) | 2,796 | 3,906 |
| Accounts payable | 7,537 | 7,310 |
| Accrued liabilities | 7,601 | 7,304 |
| Accrued rebates, returns and promotions | 9,380 | 7,210 |
| Accrued compensation and employee related obligations | 3,098 | 2,953 |
| Accrued taxes on income (Note 8) | 818 | 1,854 |
| Total current liabilities | 31,230 | 30,537 |
| Long-term debt (Note 7) | 27,684 | 30,675 |
| Deferred taxes on income (Note 8) | 7,506 | 8,368 |
| Employee related obligations (Notes 9 and 10) | 9,951 | 10,074 |
| Long-term taxes payable (Note 8) | 8,242 | 8,472 |
| Other liabilities | 8,589 | 9,017 |
| Total liabilities | 93,202 | 97,143 |
| Shareholders' equity: | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (15,222) | (13,199) |
| Retained earnings | 106,216 | 101,793 |
| Stockholders' Equity before Treasury Stock | 94,114 | 91,714 |
| Less: common stock held in treasury, at cost (Note 12) (457,519,000 shares and 437,318,000 shares) | 34,362 | 31,554 |
| Total shareholders equity | 59,752 | 60,160 |
| Total liabilities and shareholders equity | 152,954 | 157,303 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |